LAURUSLABS:NSE
Laurus Labs Ltd
₹1,978.00
arrow_downward
-0.10%(-2.00) 1D
Oct 1, 3:30:00 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LAURUSLABS...
Open
₹1,973.60
High
₹2,006.90
Low
₹1,952.10
Mkt. cap
1.07T
Avg. vol.
2.98M
Volume
1.46M
Dividend
0.10%
Quarterly dividend
₹0.50
Ex-dividend date
May 8, 2026
P/E ratio
97.80
52-wk high
₹2,055.30
52-wk low
₹843.00
EPS
₹20.23
Shares outstanding
106.44M
No. of employees
7K
Open
₹1,973.60
High
₹2,006.90
Low
₹1,952.10
Mkt. cap
1.07T
Avg. vol.
2.98M
Volume
1.46M
Dividend
0.10%
Quarterly dividend
₹0.50
Ex-dividend date
May 8, 2026
P/E ratio
97.80
52-wk high
₹2,055.30
52-wk low
₹843.00
EPS
₹20.23
Shares outstanding
106.44M
No. of employees
7K
News stories
From web sources and news partners
Moomoo
·
1 hour ago
The Next Generational AI Monopoly: Why Rezolve AI ($RZLV) is a Screaming Buy Before a 10x Repricing
Simply Wall Street
·
1 hour ago
October 2026 Founder Led Stocks To Watch
marketscreener.com
·
42 minutes ago
Gold gains as October Fed rate hike prospects fade
Profile
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
About Laurus Labs Ltd
CEOSatyanarayana Chava
Employees7.06K
Founded2005
Headquarters-
SectorPharmaceutical industry
Websitelauruslabs.com